|
|
Rwanda FDA-HMP-MA-1489
|
IRBESARTAN IMPACT 150 MG
|
Irbesartan 150mg
|
SANOFI WINTHROP INDUSTRIE,
|
Registered
|
Details →
|
|
|
Rwanda FDA-HMP-MA-1463
|
IRBESARTAN/HYDROCHLOROTHIAZIDE IMPACT 300 MG/12.5 MG FILM-COATED TABLETS
|
Irbesartan 300 mg and Hydrochlorothiazide 12,5 mg
|
TROIKAA PHARMACEUTICALS LTD,
|
Registered
|
Details →
|
|
|
Rwanda FDA-HMP-MA-1634
|
Irbesartan Impact 300 mg
|
IRBESARTAN
|
Sanofi Winthrop Industrie
|
Registered
|
Details →
|
|
|
Rwanda FDA-HMP-MA-1974
|
Irbesartan/Amlodipine Besylate Impact
|
Irbesartan/Amlodipine Besylate Impact
|
Sanofi Winthrop Industrie
|
Registered
|
Details →
|
|
|
RWANDA-FDA24/HM/0229/0111
|
Irbesartan/Hydrochlorothiazide Impact 150 mg/12,5 mg
|
Irbesartan and Hydrochlorothiazide
|
Sanofi Chimie
|
Registered
|
Details →
|
|
|
Rwanda FDA-HMP-MA-1830
|
IRBIS 150
|
Irbesartan
|
HETERO LABS LIMITED
|
Registered
|
Details →
|
|
|
Rwanda FDA-HMP-MA-1737
|
IRBIS 300
|
Irbesartan
|
M/S HETERO LABS LIMITED, UNIT-I
|
Registered
|
Details →
|
|
|
Rwanda FDA-HMP-MA-1993
|
IRBIS-HT 150/12.5
|
Irbesartan and Hydrochlorothiazide
|
M/S. Hetero Labs Limited (Unit-V)
|
Registered
|
Details →
|
|
|
Rwanda FDA-HMP-MA-1736
|
IRBIS HT -300/12.5
|
Irbesartan and Hydrochlorothiazide
|
HETERO LABS LIMITED (Unit-V)
|
Registered
|
Details →
|